0 items USD 0.00Search
Your search for "gbi research pain drug development pipeline review 2017" gave back 3475 results.
The United States market for pain management therapeutics remains a substantial growth area for pharmaceutical companies, as they continue their...
Catalog:
iGATE
September 2017
Price: USD 1,100.00
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their...
iGATE
July 2017
Price: USD 1,250.00
Respiratory diseases refers to pathological condition affecting lungs and other parts of the respiratory system. Asthma and COPD are the two most...
Catalog:
Rockville Research
May 2019
Price: USD 1,100.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
HGH is a master hormone protein responsible for growth stimulation, development and regeneration of healthy cells. Deficiency of growth hormone leads...
Catalog:
Rockville Research
March 2017
Price: USD 1,100.00
Breast cancer is one of the most fatal cancer witnessed in women and is the second leading cause of death. It refers to cancer developed in breast...
Catalog:
Rockville Research
April 2019
Price: USD 1,100.00
Insulin is a peptide hormone produced by pancreas and is central to regulating carbohydrate and fat metabolism in the body. Insulin therapy is used...
Catalog:
Rockville Research
November 2018
Price: USD 1,700.00
FDA has recently approved much-awaited first dedicated coronary bifurcated stent for treatment of cardiovascular diseases. The report “Global...
Catalog:
Rockville Research
August 2018
Price: USD 1,500.00
Advent of bioresorbable stents has brought about paradigm shift in interventional cardiology due to its promising safety and efficacy outcomes. The...
Catalog:
Rockville Research
August 2018
Price: USD 1,050.00
Assertio Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Assertio Holdings, Inc. - Strategy, SWOT and Corporate Finance Report,...
MarketLine
November 2022
Price: USD 175.00
Assertio Holdings, Inc - Strategy, SWOT and Corporate Finance Report Summary Assertio Holdings, Inc - Strategy, SWOT and Corporate Finance Report, is...
MarketLine
February 2022
Price: USD 175.00
Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance Report Summary Assertio Therapeutics Inc - Strategy, SWOT and Corporate Finance...
MarketLine
December 2020
Price: USD 175.00
Cassava Sciences Inc - Strategy, SWOT and Corporate Finance Report Summary Cassava Sciences Inc - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
January 2023
Price: USD 175.00
Blistex Inc - Strategy, SWOT and Corporate Finance Report Summary Blistex Inc - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
August 2022
Price: USD 175.00
Blistex Inc. - Strategy, SWOT and Corporate Finance Report Summary Blistex Inc. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
December 2020
Price: USD 175.00
